Cargando…
Structural basis of homologous recombination
Homologous recombination (HR) is a pathway to faithfully repair DNA double-strand breaks (DSBs). At the core of this pathway is a DNA recombinase, which, as a nucleoprotein filament on ssDNA, pairs with homologous DNA as a template to repair the damaged site. In eukaryotes Rad51 is the recombinase c...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957567/ https://www.ncbi.nlm.nih.gov/pubmed/31748913 http://dx.doi.org/10.1007/s00018-019-03365-1 |
_version_ | 1783487332369825792 |
---|---|
author | Sun, Yueru McCorvie, Thomas J. Yates, Luke A. Zhang, Xiaodong |
author_facet | Sun, Yueru McCorvie, Thomas J. Yates, Luke A. Zhang, Xiaodong |
author_sort | Sun, Yueru |
collection | PubMed |
description | Homologous recombination (HR) is a pathway to faithfully repair DNA double-strand breaks (DSBs). At the core of this pathway is a DNA recombinase, which, as a nucleoprotein filament on ssDNA, pairs with homologous DNA as a template to repair the damaged site. In eukaryotes Rad51 is the recombinase capable of carrying out essential steps including strand invasion, homology search on the sister chromatid and strand exchange. Importantly, a tightly regulated process involving many protein factors has evolved to ensure proper localisation of this DNA repair machinery and its correct timing within the cell cycle. Dysregulation of any of the proteins involved can result in unchecked DNA damage, leading to uncontrolled cell division and cancer. Indeed, many are tumour suppressors and are key targets in the development of new cancer therapies. Over the past 40 years, our structural and mechanistic understanding of homologous recombination has steadily increased with notable recent advancements due to the advances in single particle cryo electron microscopy. These have resulted in higher resolution structural models of the signalling proteins ATM (ataxia telangiectasia mutated), and ATR (ataxia telangiectasia and Rad3-related protein), along with various structures of Rad51. However, structural information of the other major players involved, such as BRCA1 (breast cancer type 1 susceptibility protein) and BRCA2 (breast cancer type 2 susceptibility protein), has been limited to crystal structures of isolated domains and low-resolution electron microscopy reconstructions of the full-length proteins. Here we summarise the current structural understanding of homologous recombination, focusing on key proteins in recruitment and signalling events as well as the mediators for the Rad51 recombinase. |
format | Online Article Text |
id | pubmed-6957567 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-69575672020-01-27 Structural basis of homologous recombination Sun, Yueru McCorvie, Thomas J. Yates, Luke A. Zhang, Xiaodong Cell Mol Life Sci Review Homologous recombination (HR) is a pathway to faithfully repair DNA double-strand breaks (DSBs). At the core of this pathway is a DNA recombinase, which, as a nucleoprotein filament on ssDNA, pairs with homologous DNA as a template to repair the damaged site. In eukaryotes Rad51 is the recombinase capable of carrying out essential steps including strand invasion, homology search on the sister chromatid and strand exchange. Importantly, a tightly regulated process involving many protein factors has evolved to ensure proper localisation of this DNA repair machinery and its correct timing within the cell cycle. Dysregulation of any of the proteins involved can result in unchecked DNA damage, leading to uncontrolled cell division and cancer. Indeed, many are tumour suppressors and are key targets in the development of new cancer therapies. Over the past 40 years, our structural and mechanistic understanding of homologous recombination has steadily increased with notable recent advancements due to the advances in single particle cryo electron microscopy. These have resulted in higher resolution structural models of the signalling proteins ATM (ataxia telangiectasia mutated), and ATR (ataxia telangiectasia and Rad3-related protein), along with various structures of Rad51. However, structural information of the other major players involved, such as BRCA1 (breast cancer type 1 susceptibility protein) and BRCA2 (breast cancer type 2 susceptibility protein), has been limited to crystal structures of isolated domains and low-resolution electron microscopy reconstructions of the full-length proteins. Here we summarise the current structural understanding of homologous recombination, focusing on key proteins in recruitment and signalling events as well as the mediators for the Rad51 recombinase. Springer International Publishing 2019-11-20 2020 /pmc/articles/PMC6957567/ /pubmed/31748913 http://dx.doi.org/10.1007/s00018-019-03365-1 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Sun, Yueru McCorvie, Thomas J. Yates, Luke A. Zhang, Xiaodong Structural basis of homologous recombination |
title | Structural basis of homologous recombination |
title_full | Structural basis of homologous recombination |
title_fullStr | Structural basis of homologous recombination |
title_full_unstemmed | Structural basis of homologous recombination |
title_short | Structural basis of homologous recombination |
title_sort | structural basis of homologous recombination |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957567/ https://www.ncbi.nlm.nih.gov/pubmed/31748913 http://dx.doi.org/10.1007/s00018-019-03365-1 |
work_keys_str_mv | AT sunyueru structuralbasisofhomologousrecombination AT mccorviethomasj structuralbasisofhomologousrecombination AT yateslukea structuralbasisofhomologousrecombination AT zhangxiaodong structuralbasisofhomologousrecombination |